Back to top

Image: Bigstock

Synchronoss Technologies (SNCR) is Oversold: Can It Recover?

Read MoreHide Full Article

Synchronoss Technologies, Inc. (SNCR - Free Report) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at SNCR given that, according to its RSI reading of 22.89, it is now in oversold territory.  

What is RSI?

RSI stands for ‘Relative Strength Index’ and it is a popular indicator used by technically focused investors. It compares the average of gains in days that closed up to the average of losses in days that closed down; readings above 70 suggest an asset is overbought, while an RSI below 30 suggests undervalued conditions are present.

Other Factors

Yet, SNCR’s low RSI value isn’t the only reason to have some optimism over a coming turnaround, as there has been plenty of positive earnings estimate revision activity as of late. This is especially true when investors take a deep dive into some of these estimate revision stats and recent changes Synchronoss Technologies' earnings consensus.    

Over the past two months, investors have seen 2 earnings estimate revisions move higher, compared with none lower, at least when looking at the key current year time frame. And the consensus estimate for SNCR has also been on an upward trend over the past 60 days, as estimates have risen from $1.94/share two months ago to just $1.99/share right now.    

If this wasn’t enough, Synchronoss Technologies also has a Zacks Rank #2 (Buy)which puts it into rare company among its peers. So, given all of these factors, investors may want to consider getting in on this stock now (or holding on), as there are some favorable trends that could bubble up for this stock before long. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

More Stock News: 8 Companies Verge on Apple-Like Run

Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.

A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Synchronoss Technologies, Inc. (SNCR) - free report >>